Zenflow
A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.
$52MSeries D
ParticipantF
F-Prime
Activity from announced rounds
Activity in this selectionUnited States · Oct 14, 2026 · Jul 17, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $102.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionTwin1 AI
Gives professionals AI-powered digital twins that scale their expertise securely
$20MSeed
Role not disclosedSilicon Data
Provides independent GPU pricing benchmarks and market data for the AI compute economy
$30.5MSeries A
Role not disclosed